[Federal Register Volume 62, Number 34 (Thursday, February 20, 1997)]
[Notices]
[Page 7792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-4260]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Arthritis and Musculoskeletal and Skin Diseases 
Special Emphasis Panel (SEP) meeting:

    Name of SEP: Alendronate.
    Date: February 18, 1997.
    Time: 3:00 p.m. - adjournment.
    Place: NIAMS Review Branch, 45 Natcher Building, Bethesda, 
Maryland 20892.
    Contact Person: Melvin H. Gottlieb, Ph.D., Natcher Building, 45 
Center Drive, Rm 5AS-25U, Bethesda, Maryland 20892-6500, Telephone: 
301-594-4952.
    Purpose/Agenda: To evaluate and review an individual contract 
proposal. The meeting will be closed in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C. The discussion of this proposal could reveal confidential 
trade secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
proposal, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Program Nos. [93.846, 
Project Grants in Arthritis, Musculoskeletal and Skin Diseases 
Research], National Institutes of Health, HHS)

    Dated: February 13, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-4260 Filed 2-14-97; 4:34 pm]
BILLING CODE 4140-01-M